Echocardiography and laboratory outcomes of COVID-19 in children with a history of Kawasaki disease: a preliminary observation

被引:1
作者
Guo, Mindy Ming-Huey [1 ,2 ,3 ,4 ]
Chang, Ling-Sai [1 ,2 ,3 ]
Chen, Yu-Jhen [1 ,2 ,3 ]
Kuo, Ho-Chang [1 ,2 ,3 ,5 ]
机构
[1] Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan
[2] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan
[3] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[4] Chung Shan Med Univ, Sch Med, Taichung, Taiwan
[5] Kaohsiung Chang Gung Mem Hosp, Dept Resp Therapy, Kaohsiung, Taiwan
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2023年 / 10卷
关键词
Kawasaki disease; COVID-19; echocardiography; vaccine; coronary artery lesions;
D O I
10.3389/fcvm.2023.1127892
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundInfection with SARS-CoV-2 virus has been associated with cardiovascular sequelae including multisystem inflammatory syndrome (MIS-C) in children. Patients with a prior history of Kawasaki disease, may be more susceptible to changes in echocardiographic or laboratory findings after COVID-19. The objective of this study was to investigate the echocardiographic and laboratory findings in children with a prior history of Kawasaki disease after SARS-CoV-2 infection.Materials and methodsIn this study, we performed a retrospective chart review of 41 children younger than 18 years old who were diagnosed with COVID-19 from April to August of 2022 and had a prior history KD. We included echocardiography and blood draw data obtained at the last outpatient follow-up at our hospital for KD, and within 4 months of SARS-CoV-2 infection. Echocardiographic data obtained from 82 age-matched and gender matched controls were also included for comparison.ResultsWe found that COVID-19 resulted in slightly higher RCA Z-scores within the first month after infection (mean +/- SE, 1.20 +/- 0.18 vs. 0.83 +/- 0.18, p = 0.030), although this increase did not result in coronary artery dilatation, defined as a Z-score of at least 2.5. In addition, we found that degree of RCA dilatation after COVID-19 infection was negatively correlated with the change in monocyte percentage (Pearson's correlation coefficient-0.363, p = 0.020). Moreover, RCA Z-score changes were lower in patients who received at least one dose of mRNA COVID-19 vaccine when compared those who did not receive any (mean +/- SE, -0.23 +/- 0.16 vs. 0.39 +/- 0.17, p = 0.031).ConclusionIn this pilot study we found that COVID-19 infection resulted in slightly higher RCA Z-scores in children with a prior history of KD, although not large enough to be classified as coronary aneurysms. While these changes could be the result of measurement imprecision or interobserver variation, further study of the cardiac outcomes of COVID-19 infection in children with a prior history of KD are needed in the future.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Risk of Kawasaki Disease/Multisystem Inflammatory Syndrome Following COVID-19 Vaccination in Korean Children: A Self-Controlled Case Series Study
    Kim, Suyeon
    Ko, Hwa Yeon
    Oh, Jeongin
    Yoon, Dongwon
    Kim, Ju Hwan
    Choe, Young June
    Shin, Ju-Young
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2025, 40 (03)
  • [42] Characteristics of Children With Kawasaki Disease-Like Signs in COVID-19 Pandemic: A Systematic Review
    Mardi, Parham
    Esmaeili, Marzieh
    Iravani, Parisa
    Abdar, Mohammad Esmail
    Pourrostami, Kumars
    Qorbani, Mostafa
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [43] Kawasaki-Like Disease in Children during COVID-19 Pandemic: Two Case Reports
    Ferdosian, Farzad
    Samadzadeh, Golnaz
    Nafei, Zahra
    INTERNATIONAL JOURNAL OF PEDIATRICS-MASHHAD, 2021, 9 (10): : 14624 - 14629
  • [44] No relationship was observed between Kawasaki disease and COVID-19 in Japan
    Nakamura, Yosikazu
    PEDIATRICS INTERNATIONAL, 2021, 63 (08) : 977 - 977
  • [45] Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings
    Marzano, Angelo Valerio
    Cassano, Nicoletta
    Moltrasio, Chiara
    Verdoni, Lucio
    Genovese, Giovanni
    Vena, Gino Antonio
    DERMATOLOGY, 2022, 238 (01) : 35 - 43
  • [46] Cost-effective use of echocardiography in children with Kawasaki disease
    Scott, JS
    Ettedgui, JA
    Neches, WH
    PEDIATRICS, 1999, 104 (05) : art. no. - e57
  • [47] Research trends on causes of Kawasaki disease in the COVID-19 era: focus on viral infections
    Lee, Young Hwan
    CLINICAL AND EXPERIMENTAL PEDIATRICS, 2023, 66 (01) : 1 - 11
  • [48] Kawasaki Disease- Management Strategies Given Symptoms Overlap to COVID-19: A Review
    Wang, Linna
    Zhang, Sheng
    Ma, Ji
    Ni, Jing
    Wang, Juyan
    Li, Xiaohong
    Mu, Zhilong
    Han, Wei
    He, Gaitao
    Ma, Lei
    Shah, Jenifei
    Shah, Jay
    Jiao, Fuyong
    JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2021, 59 (236) : 417 - 424
  • [49] Exploring the Therapeutic Potential of Vitamin D in Kawasaki Disease and Its Interplay with the COVID-19
    Visuddho, Visuddho
    Welliam, Yongki
    Aldian, Fan Maitri
    Sampurna, Mahendra Tri Arif
    Irzaldy, Abyan
    TURKISH ARCHIVES OF PEDIATRICS, 2024, 59 (05): : 432 - 439
  • [50] COVID-19 in Children With Liver Disease
    Di Giorgio, Angelo
    Hartleif, Steffen
    Warner, Suzan
    Kelly, Deirdre
    FRONTIERS IN PEDIATRICS, 2021, 9